About 1,300,000 results
Open links in new tab
  1. Tuberculosis (TB) | Tuberculosis (TB) | CDC

    Public Health Professionals Information for Tuberculosis Programs CDC has resources, information, and guidance to support U.S. tuberculosis programs.

  2. About Tuberculosis | Tuberculosis (TB) | CDC

    Jan 17, 2025 · About Tuberculosis Key points Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis. Two TB-related conditions exist: inactive TB and active TB …

  3. Clinical Guidelines | Tuberculosis (TB) | CDC

    Jan 6, 2025 · This page provides a list of selected clinical guidelines related to tuberculosis (TB) topics. Guidelines are sorted by topics: testing and diagnosis, treatment, drug resistance, …

  4. Tuberculosis: Causes and How It Spreads | Tuberculosis (TB) | CDC

    Jan 17, 2025 · Tuberculosis: Causes and How It Spreads Key points Tuberculosis (TB) germs spread through the air from one person to another. TB germs can get into the air when …

  5. Testing for Tuberculosis | Tuberculosis (TB) | CDC

    Jun 17, 2024 · Testing for Tuberculosis Key points There are two types of tests for tuberculosis (TB) infection: the TB blood test and the TB skin test. A positive test result for TB infection …

  6. Tuberculosis (TB) | Tuberculosis | CDC

    La tuberculosis o TB es causada por una bacteria llamada Mycobacterium tuberculosis.

  7. Signs and Symptoms of Tuberculosis | Tuberculosis (TB) | CDC

    Jan 17, 2025 · Common symptoms of active tuberculosis disease include cough, chest pain, and coughing up blood.

  8. What You Need to Know About Tuberculosis Fact Sheet

    Mar 1, 2024 · What You Need to Know About Tuberculosis provides basic information on the transmission, symptoms, testing, and treatment of tuberculosis (TB). The fact sheet is …

  9. Tuberculosis Data | CDC

    CDC publishes data on a variety of tuberculosis (TB) topics to track progress towards elimination.

  10. Clinical Overview of Tuberculosis | Tuberculosis (TB) | CDC

    Jan 6, 2025 · CDC and the National Tuberculosis Coalition of America preferentially recommend short-course, rifamycin-based, 3- or 4-month latent TB infection treatment regimens over 6- or …